GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …
Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …
Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …
Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …